Oncolytics Biotech® Announces Clinical and Biomarker Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Checkpoint Inhibitor Combination in Pancreatic Cancer

Press/Media: Press / Media

PeriodMay 20 2021

Media coverage

5

Media coverage